AUMAX BIOSCIENCE PHARMACEUTICAL LLP

LLPIN ACS-3903

Limited Liability PartnershipIncorporated 1 November 2025

AUMAX BIOSCIENCE PHARMACEUTICAL LLP is a limited liability partnership incorporated on 1 November 2025. Its LLPIN is ACS-3903 and it is registered in Vadodara, Gujarat. Its main business activity is manufacture of pharmaceuticals, medicinal chemical and botanical products (NIC 21). The partners' total contribution is ₹5,00,000. Its designated partners are CHETANKUMAR RATHOD, DIVYARAJESINH JADEJA, KRUNALKUMAR PRAJAPATI and RAJESHRIBEN SHAH.

LLP details

Name
AUMAX BIOSCIENCE PHARMACEUTICAL LLP
LLPIN
ACS-3903
Type
Limited Liability Partnership
Date of incorporation
1 November 2025
Registrar of Companies
—
Total contribution
₹5,00,000
Business activity
Manufacture of pharmaceuticals, medicinal chemical and botanical products
NIC code
21
State
Gujarat
District
Vadodara

Registered office: FF 56, Samanvay Status II, Atladara, Vadodara, Gujarat, 390020

Designated partners

  • CHETANKUMAR RATHODDesignated Partner
  • DIVYARAJESINH JADEJADesignated Partner
  • KRUNALKUMAR PRAJAPATIDesignated Partner
  • RAJESHRIBEN SHAHDesignated Partner

First-year compliance calendar

Due dates worked out from the incorporation date. Check the latest MCA notifications for extensions.

ComplianceDue
File the LLP agreement (Form 3)within 30 days of incorporation1 December 2025
Annual return (Form 11)within 60 days of the financial year's end30 May 2026
Statement of account & solvency (Form 8)within 30 days of six months from the year's end30 October 2026
Income tax return (ITR-5)31 October if the accounts are audited31 July 2026

Never miss an ROC deadline for your clients

Finexo's practice management software tracks INC-20A, AOC-4, MGT-7, LLP Form 8 and Form 11 for every client company, assigns the work to your team and reminds clients before the due date.

See Finexo for CA firms

More new companies in Vadodara

More companies and LLPs

Search another company

Details from Ministry of Corporate Affairs records, last updated 12 October 2026.